Mind Medicine (MindMed) Inc logo

Mind Medicine (MindMed) Inc

Mind Medicine, Inc. operates as a psychedelic medicine biotech company. They focus on discovering, developing, and deploying psychedelic inspired medicines and therapies to address addiction and mental illness. Mind Medicine's research management team is led by Jim DeKorne in Oakland, CA. Jim has discovered uses for psychedelics in a diverse range of fields since the 1960s. These healthcare applications span illness management and palliative care to prevention strategies in psychiatry and drug abuse treatment. The Company is also exploring treatments for post-traumatic stress disorder (PTSD), as well as to optimize performance in individuals engaged in occupations requiring focus, problem solving, and creative abilities, such as medical workers, pilots, nuclear facility technicians, and first responders. Mind Medicine intends to conduct clinical trials leading to Federal Drug Administration approval of its lead candidate MindMed™—a combination of psychotherapy with the non-hallucinogenic fractionated doses of DMT.

Latest events on Quartr

Previous Events for Mind Medicine (MindMed) Inc

Ticker

MNMD

Country

United States of America

About the company

https://mindmed.co/

Investor Relations page

https://mindmed.co/investor-resources/#downloads

Dig deeper into the fundamentals using Quartr - Investor relations

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
Android play link
App store link
Quartr app screenshot